Article

AAO meeting kicks off with speakers focusing on blindness prevention

The 2006 Joint Meeting of the American Academy of Ophthalmology and the Asia Pacific Academy of Ophthalmology in Las Vegas will feature two acclaimed physicians at the opening session on Sunday, Nov. 12 from 8:30 to 10 a.m.

The 2006 Joint Meeting of the American Academy of Ophthalmology and the Asia Pacific Academy of Ophthalmology in Las Vegas will feature two acclaimed physicians at the opening session on Sunday, Nov. 12 from 8:30 to 10 a.m.

Lawrence (Larry) Brilliant, MD, will present "Blindness Prevention: Challenges to Meet" and Alfred (Al) Sommer, MD, will present "Reaching our Patients: Those We Know and Those We Don't."

Dr. Brilliant is credited with ending smallpox in India and co-founded The Well with renowned futurist Stewart Brand. He is the founder of the international health nonprofit organization, the Seva Foundation, which has helped restore sight to nearly 2 million people worldwide.

Dr. Sommer is former director of the Dana Center for International Ophthalmology at Johns Hopkins University and the 1997 Lasker Award recipient.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
(Image credit: Ophthalmology Times) Oluwatosin U. Smith talks Glaukomtecken
ASCRS 2025: Eva Kim, MD, discusses implantable collamer lenses and high myopia.
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
© 2025 MJH Life Sciences

All rights reserved.